Brief: Argent Biopharma Ltd To Delist from London Stock Exchange
Nov 29 (Reuters) - London Stock Exchange Group PLC
LSEG.L :
* ARGENT BIOPHARMA LTD - ASX & LSE LISTING UPDATE
* ARGENT BIOPHARMA LTD: NOTICE OF INTENTION TO DELIST FROM
LONDON
STOCK EXCHANGE
* ARGENT BIOPHARMA LTD: WILL MAINTAIN ITS LISTINGS ON ASX
AND
OTCQB VENTURE MARKET
Source text: ID:
Further company coverage: LSEG.L
(Reporting by Tom Wilson)
((T.Wilson@thomsonreuters.com; Reuters Messaging:
t.wilson.thomsonreuters.com@reuters.net))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group